Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2002
09/03/2002US6444672 Heterocyclic derivatives and their use as antithrombotic agents
09/03/2002US6444615 Compounds effective as preemergent and postemergent herbicides
09/03/2002CA2234051C Novel isoquinoline derivatives
09/01/2002CA2373578A1 .beta.3, agonists and uses thereof
08/2002
08/29/2002WO2002066474A1 Bis-triazinylaminobenzoxazole derivatives
08/29/2002WO2002066473A1 8’4-’3-(5-fluoro-1h-indol-3yl) propyl!-1-piperazynyl!-2-methyl-2h-1,4-benzoxazin -3 (4h)- one methanesulfonate with high affinity for the dopamine d 2 receptor and the serotonin reuptake site
08/29/2002WO2002066472A1 New phenylpiperazines
08/29/2002WO2002066471A1 Novel 1, 5-dialkyl-3-(3-oxo-3, 4-dihydro-2h-benzol[1, 4] oxazin-6-yl)-6-thioxo-[1, 3, 5] triazinan-2, 4-diones
08/29/2002WO2002066470A1 Substituted alkylamine derivatives and methods of use
08/29/2002WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066463A1 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
08/29/2002WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors
08/29/2002WO2002066460A1 Chemical compounds
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066440A1 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
08/29/2002WO2002055516A3 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a)
08/29/2002WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/29/2002WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
08/29/2002WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists
08/29/2002WO2001087288A8 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
08/29/2002WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120152 Aminoaryl oxazolidinone N-oxides
08/29/2002US20020120146 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3.
08/29/2002US20020119998 Oxadiazole, thiadiazoles or triazole metal derivatives reacted with an amine containing aldehyde, deprotecting, coupling with an acid and oxidizing to create substituted oxadiazole, thiadiazole or triazole peptoids
08/29/2002US20020119985 Serine protease inhibitors
08/29/2002US20020119983 Novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
08/29/2002US20020119980 Antihistamines, antiallergens
08/29/2002US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent
08/29/2002US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
08/29/2002US20020119971 Antiinflammatory agents; skin disorders; central nervous system disorders
08/29/2002CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2411973A1 New phenylpiperazines
08/28/2002EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
08/28/2002EP1234820A1 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
08/28/2002EP1234819A1 Processes for production of oxadiazoline derivatives
08/28/2002EP1233963A2 Novel sulfonyl oxazole amines
08/28/2002EP1233962A2 Novel heterocyclic compounds and their use as medicines
08/28/2002EP1233769A1 Novel compounds
08/28/2002EP1140926B1 Azadioxacycloalkenes and their use for combating harmful fungi and animal pests
08/28/2002EP1073653B1 Novel 2-heterocyclically substituted dihydropyrimidines
08/28/2002EP1054874B1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor
08/28/2002CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/28/2002CN1089762C Benzimidazole compounds and their use as modulators of GABAA receptor complex
08/28/2002CN1089761C Sidechain-bearing texanes and its preparing process
08/28/2002CN1089760C Process for production of 4-substituted-3-halogeno-1,4-benzoxazepine derivative and salts thereof
08/27/2002US6441195 Substituted sulphonylamino(thio) carbonyl compounds
08/27/2002US6441188 Aminoaryl oxazolidinone N-oxides
08/27/2002US6441186 Epothilone analogs
08/27/2002US6441021 Type-iv collagenase inhibitors
08/27/2002US6441012 Chemical compounds
08/27/2002US6441005 Oxazolidinone compounds and compositions, and methods of using the same
08/27/2002US6441004 Monocyte chemoattractant protein-1 inhibitor compounds
08/27/2002US6441000 Compounds useful in therapy
08/27/2002US6440996 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/27/2002US6440995 Quinolin-4-yl derivatives
08/27/2002US6440961 Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
08/27/2002US6440899 Cyclohexenonedioxothiochromanoyl derivatives
08/27/2002CA2045955C Indole derivatives
08/22/2002WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof
08/22/2002WO2002064575A1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents
08/22/2002WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/22/2002WO2002064572A1 Quinazolines as mmp-13 inhibitors
08/22/2002WO2002064571A1 Pyrimidine matrix metalloproteinase inhibitors
08/22/2002WO2002064558A2 Oxazole derivatives, their preparation and their use as cytokine inhibitors
08/22/2002WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
08/22/2002WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/22/2002WO2002064119A1 Tablets quickly disintegrated in oral cavity
08/22/2002WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002WO2002063957A2 Selective substituted aryl ketone and safener based herbicides
08/22/2002WO2002045652A3 Tyrosine kinase inhibitors
08/22/2002WO2002040471A3 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/22/2002WO2002040008A3 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists
08/22/2002WO2002032893A3 Piperidine compounds as anti-allergic
08/22/2002WO2000020414A9 Piperidyloxadiazoles as dopamine receptor antagonists
08/22/2002US20020115868 Novel process for making 5-substituted pyrazoles
08/22/2002US20020115863 Hydroxamate derivatives that inhibit peptidyl deformylase (PDF), antimicrobials and antibiotics
08/22/2002US20020115854 Thrombin or factor Xa inhibitors
08/22/2002US20020115701 Have antipyretic action, analgesic action, antiinflammatory action, and particularly, selective inhibitory action on cyclooxygenase-2; ketomethylene intermediates
08/22/2002US20020115675 Treating particularly tumoral diseases, diseases of the lungs and respiratory tract.
08/22/2002US20020115670 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
08/22/2002US20020115669 Treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy.
08/22/2002US20020115666 N-phenethyl-2-aryl-2-(4-(oxy-or amino-carbonylamino)piperidin-1-yl)acetamide derivatives
08/22/2002US20020115651 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
08/22/2002US20020114770 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits
08/22/2002CA2437760A1 Selective substituted aryl ketone and safener based herbicides
08/22/2002CA2437122A1 Quinazolines as mmp-13 inhibitors
08/22/2002CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002CA2405532A1 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
08/21/2002EP1232153A2 Imidazole derivatives and their use as raf kinase inhibitors
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1231984A1 Phorboxazole derivatives for treating cancer
08/21/2002EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/21/2002CN1365355A Quinoline derivatives as inhibitors of MEK enzymes
08/21/2002CN1089340C Oxa-and thia-diazole muscarinic receptor antagonists